Patients to Recover Faster as West Herts Invests in Cutting Edge Robotic Surgery Technology West Hertfordshire Teaching Hospitals NHS Trust has become one of the first in the UK to adopt the new Intuitive DV5 robotic surgery platform. This advanced system is designed to enhance precision in

new robots helping surgeons remove cancers (bowel, kidney, gallbladder) with less trauma. fewer complications means faster recovery. maybe we can start treating patients better.

Menopause isn't just hot flashes?! A new study says exhaustion & fatigue are actually *more* common perimenopause symptoms. Plus, big differences in symptom severity across ethnicities. Time for more inclusive research.

Satellites to surgery: How Isro's space tech is entering hospitals' operating theatre Indian space technology, originally explored by NASA for remote surgery for astronauts in the 1970s, is now being adapted for surgical applications. This includes using "digital twin technology," simi

space tech originally for astronauts is now being used to plan surgeries with "digital twins" 🤔. kinda cool, but even with 20 million robotic surgeries done, we still can't get true tactile (touch) feedback in the robots. that's the next big hurdle.

Scientists discover bacteria can “explode” to spread antibiotic resistance Researchers have found a surprising new mechanism by which bacteria spread antibiotic resistance. They discovered that bacteria repurpose ancient virus-like particles, called gene transfer agents (GTA

Antibiotic resistance is spreading in a crazy way: bacteria "explode" to release DNA! Scientists found genes (LypABC) trigger cells to burst open, spreading resistance. More research needed, but wow.

Nuvaxovid™ COVID-19 Vaccine Showed Better Tolerability than mNEXSPIKE in Head-to-head Sanofi-led Pha Sanofi presented positive results from the COMPARE study, a Phase 4 clinical trial, indicating that Novavax's protein-based Nuvaxovid™ COVID-19 vaccine demonstrated statistically significant lower sys

COVID vaccine update: Novavax's Nuvaxovid™ seems to have fewer reported side effects (like fever or chills) than Moderna's mNEXSPIKE, per a Phase 4 trial. Good to have options!

Stem cell progress for type 1 diabetes: Researchers made insulin-producing cells in the lab that regulated blood sugar in mice. It's another step toward better treatments for this disease.

Your gut bugs, your microbiome, might predict if melanoma comes back after surgery & immunotherapy. Early study of 674 pts showed the *mix* of bacteria was 94% accurate at predicting recurrence. Personalized treatment maybe someday?

Speakfloe — AI English Tutor Practice speaking English with an AI tutor. Check your level for free.

Free English level assessment call

app.speakfloe.com#/onboarding/...

Researchers make breakthrough with 'superbug' pathogen Taiwanese researchers have unlocked a key mechanism of *Acinetobacter baumannii*, a highly drug-resistant 'superbug' with a mortality rate of between 30 percent and 70 percent. They discovered that an

Superbugs are scary! But researchers found a weak spot in *Acinetobacter baumannii* (a germ with up to a 70% mortality rate). Targeting it could help us develop new treatments. This is how we fight back!

Anti-amyloid drugs for Alzheimer's? New Cochrane review says they don't make a noticeable difference in patients' lives, despite trial results. Plus, risk of brain swelling. Something to consider.

57% lower risk of death! A new phase 3 trial showed that orforglipron, an oral diabetes drug, significantly improved survival rates compared to insulin. Progress.

Robotic Hip Replacement Yields Low Reoperation Rate A research team from the University of Hong Kong (HKUMed) has demonstrated that robotic total hip replacement leads to a significantly lower reoperation rate compared to the conventional surgical tech

Robotic hip replacement had a lower reoperation rate (0.6%) than conventional surgery (2.5%) in a study of 553 patients. Precision matters for long-term mobility.

Lilly's Foundayo (orforglipron) Phase 3 Trial Shows Cardiovascular Safety and Reduced All-Cause Deat A Phase 3 clinical trial, ACHIEVE-4, demonstrated that Eli Lilly's drug Foundayo (orforglipron) is safe for cardiovascular health and significantly reduced the risk of death from any cause in adults w

For T2 diabetes, we used to focus on just managing blood sugar. Lilly's Foundayo (orforglipron) Phase 3 trial shows a *57% reduction* in all-cause death in patients with elevated cardiovascular risk. That's a change in perspective.

Cool HIV research: Scientists are using mRNA (like in some COVID vaccines) to make hidden HIV viruses visible, so our immune systems can fight them. Early tests show it's working!

Advancing reconstructive transplantation: Innovations in organ preservation Researchers at Johns Hopkins are developing advanced methods to extend the viability of donor organs, particularly for complex reconstructive transplants such as hands and faces. Their innovative work

Imagine a world where more donor organs become available. Researchers are improving organ preservation for complex transplants. One-quarter of kidneys are discarded now due to time constraints.🤯

Pancreatic cancer is a tough one, but a Phase 3 trial of a new drug (daraxonrasib) nearly doubled survival time: 13 months vs 6.7 with chemo. I didn't expect that level of impact.

Unexpected Source of Salt May Be Raising Blood Pressure For Millions A new analysis suggests that rising sea levels are leading to saltwater infiltrating freshwater sources, causing saltier drinking water. This environmental change is unexpectedly linked to higher bloo

Salty drinking water from rising sea levels is linked to a 26% higher risk of hypertension (high blood pressure). Something to keep in mind, especially near the coasts.

Two new TB vaccine candidates show promise but fail to stop infection Results from a large trial in India show that two new tuberculosis (TB) vaccine candidates, VPM1002 and Immuvac, are safe and can reduce the risk of developing active disease in adults and older child

New TB vaccines are safe and help, but sadly don't prevent infection. Still, progress! Another vaccine candidate looks more promising.

Allogene's 'Off-the-Shelf' CAR T Therapy Shows Promising Early Results in Lymphoma, Reducing Residua Early findings from a Phase 2 clinical trial indicate that Allogene Therapeutics' experimental off-the-shelf CAR T-cell therapy, cema-cel, significantly clears residual disease in patients with large

CAR-T therapy is usually custom-made, taking weeks. This "off-the-shelf" version cleared cancer in 58% of patients vs 17% normally. Imagine 6/10 tumors GONE instead of 2/10 in the same time. Early, but promising!

A Distinct New Type of Diabetes Is Now Officially Recognized The International Diabetes Federation (IDF) has officially recognized a fifth form of diabetes, previously known as malnutrition-related diabetes mellitus (MRDM), after decades of debate. This reclass

imagine being treated for type 2 diabetes when you actually have a totally different kind! this newly recognized type 5 diabetes, stemming from malnutrition, impacts millions and needs proper diagnosis. it's about treating the *right* disease.

www.instagram.com/speakfloe/

From cells to sentences 🧬➡️🗣️

Yes, I talk about biology here, but I also teach English on my Instagram.
So if you want to improve your English while keeping your brain active, come follow me there 😄

www.instagram.com/speakfloe/

Study explores why fasting can lead to a longer lifespan New research from UT Southwestern Medical Center, published in Nature Communications, suggests that the life-extending benefits of intermittent fasting are not primarily due to the fasting period itse

Fasting can extend lifespan by 60%?! Turns out, it's not just *what* you skip (food) but *when* you start eating again that matters. Refeeding after fasting seems key, at least in worms. 🤔 More to come!

People with diabetes have almost a 60% higher risk of developing MS (multiple sclerosis, a disease of the brain & spinal cord). I wish this link was getting more attention.

New Drug for Rare Childhood Dementia Wins FDA Accelerated Approval The FDA has granted accelerated approval to Avlayah, a pioneering drug that uses "brain shuttle" technology to effectively cross the blood-brain barrier. This treatment is for Hunter Syndrome, a rare

91% reduction! New drug Avlayah cut heparan sulfate (a brain buildup) in kids with Hunter Syndrome. It uses "brain shuttle" tech to cross the blood-brain barrier. Could unlock new Alzheimer's treatments.

Uveal melanoma is a rare eye cancer. Early trial results show a new drug combo more than doubled how long patients lived *without* their cancer getting worse: 6.9 months vs 3.1 months on older treatments. This is significant.

AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinu New results from the Phase 2 IMGN853-0420 trial indicate that the drug mirvetuximab soravtansine-gynx (ELAHERE®) when combined with carboplatin, and then continued as a single treatment, is effective

Ovarian cancer tidbit: A new combo therapy shrank tumors in 63% of patients (with high folate receptor alpha, a protein on tumor cells). Imagine 6 of 10 people seeing a benefit. Phase 2, but promising!

New bipolar treatments in the pipeline! Bysanti, a new antipsychotic (calms the brain), just got approved. Over 100,000 patients' data showed it's safe. That's a LOT of data! Knowing how meds work is important.

Spyre Announces Potential Best-in-Class SPY001 Part A Induction Results from SKYLINE Trial in Modera Spyre Therapeutics has announced positive 12-week induction data from Part A of its Phase 2 SKYLINE trial for SPY001, an investigational antibody designed to treat moderate-to-severely active ulcerati

Ulcerative colitis is awful. Promising early trial (phase 2) results show an investigational antibody significantly reduced disease activity. Specifically, it improved Robart's Histopathology Index (RHI) score by 9.2 points! Something to keep an eye on.

Wow, scientists built a virus from scratch to kill antibiotic-resistant bacteria! Custom virus therapy may be coming sooner than we thought.

Early epigenetic changes shape infant gut microbiome development and link to neurodevelopmental cond A new study reveals that epigenetic changes present at birth significantly influence how an infant's gut microbiome develops during their first year of life. These early interactions between genetics

remember when we thought genes were destiny?🤯 new research shows early gut bacteria linked to infant development. turns out some "good" bacteria are associated with reduced chances of neurodevelopmental conditions later in life. this is so cool!